Author:
Arslan Ibis Kamuran,Kucucuk Seden
Publisher
Springer International Publishing
Reference54 articles.
1. Mamounas EP, Anderson SJ, Dignam JJ, Bear HD, Julian TB, Geyer CE Jr, et al. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol. 2012;30(32):3960–6.
2. De Felice F, Osti MF, De Sanctis V, Musio D, Tombolini V. Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era. Expert Rev Anticancer Ther. 2017;17(5):481–5.
3. Garg AK, Buchholz TA. Influence of neoadjuvant chemotherapy on radiotherapy for breast cancer. Ann Surg Oncol. 2015;22(5):1434–40.
4. National Cancer Institute Trial. Standard or comprehensive radiation therapy in treating patients with early-stage breast cancer previously treated with chemotherapy and surgery.
www.clinicaltrials.gov
.
5. Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, et al. Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials. Int J Radiat Oncol Biol Phys. 2005;61(4):1045–53.